相关实验视频
Updated: Sep 11, 2025

08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
3.8K
儿童过敏接触性皮肤炎的变化频谱:西班牙的一项前性多中心研究
Nidia Planella-Fontanillas1,2, David Pesqué1,3, Leopoldo Borrego4
1From the Department of Dermatology, Hospital del Mar Research Institute, Barcelona, Spain.
Dermatitis : contact, atopic, occupational, drug
|August 18, 2025
概括
过敏性接触性皮肤炎 (ACD) 影响儿童,贴片检测显示过敏率高. 新兴的过敏原,如林纳醇和烯氧化,需要注意,以更好地治疗儿科ACD.
科学领域:
- 皮肤病学 皮肤病学
- 儿科 儿科 儿科
- 过敏学 过敏学
背景情况:
- 过敏性接触性皮肤炎 (ACD) 的患病率在儿童中正在上升,显示出与年龄相关的差异.
- 了解这些模式对于有效的诊断和管理至关重要.
- 儿科ACD需要最新的临床和流行病学数据.
研究的目的:
- 更新儿科ACD的临床和流行病学特征.
- 为了确定敏感化频率和阳性补丁试验的相关性.
- 分析儿科ACD的特定年龄变化.
主要方法:
- 使用REIDAC注册表对儿科患者 (0-16岁) 进行前性多中心研究.
- 分为两个年龄组:0-5岁和6-16岁.
- 用GEIDAC基线和扩展系列 (2019年1月至2023年12月) 进行的补丁测试.
主要成果:
- 508名儿童接受了补丁检测;179名 (35.2%) 受到敏感.
- 在0-5岁组 (n=41) 中,24.4%的人敏感;面部和手部受影响最多. 林醇和烯氧化是主要的过敏原.
- 在6至16岁组 (n=467),有36.2%的患者敏感;面部和手部受影响最多. 林醇氧化物和甲基异苏醇是主要的过敏原.
结论:
- 在这两个儿科年龄组的高敏感率强调了贴片检测的重要性.
- 临醇和烯氧化物被确定为重要的新兴敏感剂.
- 针对特定年龄的治疗策略对于改善儿科ACD结果至关重要.
相关概念视频
Changes in Skin Color: Clinical Perspectives
2.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.2K
Allergic Reactions
28.6K
Overview
28.6K
Allergic Drug Reactions
978
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
978
Hypersensitivities
1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K

